Aehr Test Systems
NASDAQ:AEHRSemiconductors
+$5.32 today
- Market cap
- $1.62B
- Beta
- 3.18
- P/E (TTM)
- -317.1
- EPS (TTM)
- -$0.37
Volume 1.83M
Average 2.97M
AEHR Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Aehr Test SystemsNASDAQ: AEHR
Accounts Receivables · Q4 FY2026 · quarter ended May 2026
Accounts receivables growth accelerates
Q4 FY2026 accounts receivables of $5.69M (cash outflow) rose 174.4% year over year, ahead of the +8.9% change in trailing-twelve-month accounts receivables. Sequentially, it rose 278.6% from the prior quarter. Over 3 fiscal years it compounded at -4.4% a year.
Context
- Accounts receivables amounted to 6.6% of revenue in FY2026, up 1.5 pp from a year earlier.
- Accounts receivables increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +174.4% holds above the trailing-twelve-month pace of +8.9%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2026
- (3.31M) USD
- Year-over-year change
- -8.9%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2026 | 2026-05-29 | (3.31M) | -8.9% |
| FY2025 | 2025-05-30 | (3.04M) | -144.7% |
| FY2024 | 2024-05-31 | 6.79M | +279.3% |
| FY2023 | 2023-05-31 | (3.79M) | +51.6% |
| FY2022 | 2022-05-31 | (7.83M) | — |
Accounts Receivables vs competitors
How AEHR compares with its peers on the latest reported figures
- AEHR's LTM May 2026 accounts receivables of $3.31M is the smallest of the 5 companies compared; the peer median is $20.03M.
- Its year-over-year change of +8.9% is the 2nd highest of 5, against a peer median of -349.3%.
- Accounts receivables amounts to 6.5% of revenue for AEHR, versus a peer median of 7.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $657.27M | -1387.6% | — | 14.7% | |
| LTM Jun 2026 | $35.85M | -280.2% | — | 6.9% | |
| LTM Sep 2026 | $7.92M | +147.4% | — | 0.8% | |
| LTM Mar 2026 | $4.2M | -418.3% | -59.9% | 7.2% | |
| LTM May 2026 | $3.31M | +8.9% | -4.4% | 6.5% | |
| Peer median (excluding AEHR) | $20.03M | -349.3% | -59.9% | 7.0% | |
Competitors are the stored peer set for AEHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 May 2022 | FY2023 May 2023 | FY2024 May 2024 | FY2025 May 2025 | FY2026 May 2026 |
|---|---|---|---|---|---|
| Net Income | 9.45M | 14.56M | 33.16M | (3.91M) | (7.13M) |
| Depreciation & Amortization | 307K | 450K | 1.36M | 3.39M | 3.53M |
| Deferred Income Tax | 0 | 0 | (20.77M) | (421K) | (4.72M) |
| Stock-Based Compensation | 3.01M | 0 | 2.52M | 5.16M | 6.76M |
| Change in Working Capital | (9.56M) | (7.28M) | (14.38M) | (12.2M) | (1.79M) |
| Accounts Receivables | (7.83M) | (3.79M) | 6.79M | (3.04M) | (3.31M) |
| Inventory | (6.67M) | (9.47M) | (13.73M) | (2.44M) | 11K |
| Accounts Payables | 1.36M | 5.04M | (3.89M) | (714K) | 991K |
| Other Working Capital | 3.6M | 933K | (3.55M) | (6.01M) | 512K |
| Other Non-Cash Items | (1.7M) | 2.28M | (130K) | 584K | 33K |
| Operating Cash Flow | 1.51M | 10.01M | 1.76M | (7.4M) | (3.31M) |
| Capital Expenditures | (416K) | (1.36M) | (749K) | (4.99M) | (2.07M) |
| Acquisitions (Net) | 0 | 0 | 0 | (11.08M) | (1.8M) |
| Purchases of Investments | 0 | (33.29M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 16M | 18M | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (416K) | (18.66M) | 17.25M | (16.07M) | (3.87M) |
| Debt Repayment | (1.4M) | 0 | 0 | 0 | 0 |
| Common Stock Issued | 27.59M | 9.38M | 1.74M | 1.41M | 99.6M |
| Common Stock Repurchased | (429K) | (2.06M) | (1.6M) | (784K) | (2.36M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | (20K) |
| Financing Cash Flow | 25.76M | 7.32M | 139K | 625K | 97.21M |
| Effect of Forex Changes | 49K | (107K) | (41K) | (1.09M) | (6K) |
| Net Change in Cash | 26.9M | (1.43M) | 19.11M | (23.93M) | 90.03M |
| Free Cash Flow | 1.09M | 8.65M | 1.01M | (12.39M) | (5.38M) |
Aehr Test Systems
NASDAQ:AEHR
Intrinsic Alpha fair value
Locked
Current Price
$49.48
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.